Mastering Clinical Performance Studies under IVDR
FROM STRATEGY TO DELIVERY
Are you prepared to tackle the challenges of clinical performance studies under the IVDR?
Description
The regulatory landscape for in vitro diagnostic (IVD) devices is constantly evolving, making it critical to provide evidence of your device’s clinical performance. This webinar will delve into the strategic, regulatory, and operational aspects of conducting successful clinical performance studies.
With input from IVD experts, we’ll explore what it takes to create a robust and compliant study design, effectively source samples and sites, and meet the unique challenges posed by self-testing and near-patient testing devices. Additionally, our panel will discuss the requirements outlined in Annex XIV of the IVDR and provide tips on managing performance study applications across EU Member States.
Whether you’re preparing for a new submission or looking to refine your current approach, this session is designed to provide actionable guidance to help you succeed.
Watch the webinar on demand
What you'll learn
- Collect reliable clinical data
- Align with regulatory requirements
- Design effective study plans
- Source samples and select sites
- Self-testing and near-patient testing considerations
- Common assessment gaps from notified bodies
- Key points of Annex XIV
- Manage applications across EU Member States
Speakers
Join us as our expert speakers share valuable insights and practical knowledge drawn from extensive industry experience.
Don’t miss the opportunity to learn and engage with professionals in the field.
Annelies Rottheir
Annelies Rotthier is a senior IVD consultant. After her Ph.D. in Molecular Genetics at the VIB Institute in Antwerp, she pursued her career in the field of molecular genetics as R&D manager in the spin-off company Multiplicom and later as Director Product Development at Agilent Technologies, a major player in Next Generation Sequencing IVD applications.
She brings her experience to support companies with product development in compliance with IVD Regulation and with the transition to the new IVD Regulation. Risk management activities in accordance with ISO14971 is one of her main expertise.
Kirsten Van Garsse
Kirsten Van Garsse obtained her Master’s degree in Biomedical Sciences in 2002 from the Vrije Universiteit Brussel (VUB) and has amassed extensive experience in the In Vitro Diagnostic Medical Device Industry. She joined Qarad, now part of the QbD Group, a consulting company specialized in Regulatory Affairs and Quality Systems for the IVD and Medical Device industry, at the end of 2017.
In her role as Director of Authorized Representative Services & Manager of IVD Regulatory Affairs, Kirsten applies her wealth of experience to Regulatory Affairs projects, adeptly translating regulations into compliant business processes and applications. Additionally, she oversees the various Representation Services offered by Qarad, ensuring clients receive expert support in navigating regulatory requirements.
Watch here
Submit your contact details to access the full webinar anytime. Don’t miss out on valuable insights and actionable strategies from our industry experts.